A common mechanism of clinical HIV-1 resistance to the CCR5 antagonist maraviroc despite divergent resistance levels and lack of common gp120 resistance mutations.
Roche M, Salimi H, Duncan R, Wilkinson BL, Chikere K, Moore MS, Webb NE, Zappi H, Sterjovski J, Flynn JK, Ellett A, Gray LR, Lee B, Jubb B, Westby M, Ramsland PA, Lewin SR, Payne RJ, Churchill MJ, Gorry PR.
Roche M, et al. Among authors: salimi h.
Retrovirology. 2013 Apr 20;10:43. doi: 10.1186/1742-4690-10-43.
Retrovirology. 2013.
PMID: 23602046
Free PMC article.